SRDX News and Press, Surmodics Inc. From 08/28/19

Study designed to evaluate safety, efficacy of the company’s next-generation SurVeil™ drug-coated balloon Company Raises 2019 Revenue and EPS Guidance Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the heal...

Surmodics, Inc. (SRDX) Q3 2019 Earnings Conference Call July 31, 2019, 05:00 PM ET Company Participants Tim Arens - VP, Corporate Development & Strategy, Interim VP, Finance & CFO Gary Maharaj - President & CEO Conference Call Participants Mike Mattson - Needham a...

Surmodics (NASDAQ: SRDX ): Q3 Non-GAAP EPS of $0.15 beats by $0.09 ; GAAP EPS of $0.11 beats by $0.11 . More news on: Surmodics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2019 third quarter ended June 30, 2019, and updated its financial outlook for fiscal 2019. Summary of Third Quarter...

Webcast is Live at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its third quarter fiscal 2019 conference call on Wednesday, July 31...

Webcast is Live on Tuesday, June 4, at 10:30 a.m. (ET) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president and chief executive officer, and Tim Arens, vice ...

Surmodics, Inc. (SRDX) Q2 2019 Earnings Conference Call May 1, 2019 17:00 ET Company Participants Timothy Arens - VP, Corporate Development & Strategy, Interim VP, Finance & CFO Gary Maharaj - President & CEO Conference Call Participants Mike Matson - Needham &...

Surmodics (NASDAQ: SRDX ): Q2 Non-GAAP EPS of $0.07 beats by $0.09 ; GAAP EPS of $0.09. More news on: Surmodics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Updates Fiscal 2019 Guidance Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2019 second quarter ended March 31, 2019, and updated its financial outlook for fis...

Webcast is Live at 4 p.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2019 conference call on Wednesday, May 1...